Host Jim Cramer recommended AstraZeneca as an investment in a "Mad Money" lightning round.
In a "Mad Money" lightning round, host Jim Cramer recommended AstraZeneca as an investment due to its strong team, impressive formulations in oncology and heart, and mentioning their GLP-1 efforts. Cramer also advised against investing in Hawaiian Electric and suggested Eli Lilly as a better option than Viking Therapeutics, with a disclaimer that the CNBC Investing Club Charitable Trust holds shares of Eli Lilly.
May 31, 2024
8 Articles